Evidence map›Paper›PMID 40989209›Full record

ReviewRwanda journal of medicine and health sciences2025

Exploring the Epidemiology, Transmission Dynamics and Public Health Interventions of Marburg Viral Disease: A Scoping Review of Global Evidence.

Girum Sebsibie Teshome, Teklemariam Gulte Ketema, Philomene Uwimana, Dieudonne Kayiranga, Joselyne Rugema, Ancille Murekatete, Jean Pierre Manirafasha, Delphine Mukandayisaba

Abstract readReview
In one paragraph

Review in Rwanda journal of medicine and health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Girum Sebsibie TeshomeSchool of Nursing and Midwifery, College of Medicine and Health Science, University of Rwanda, Kigali, Rwanda.
Teklemariam Gulte KetemaArba-Minch University, school of Nursing and Midwifery, Arba-Minch, Ethiopia.
Philomene UwimanaSchool of Nursing and Midwifery, College of Medicine and Health Science, University of Rwanda, Kigali, Rwanda.
Dieudonne KayirangaSchool of Nursing and Midwifery, College of Medicine and Health Science, University of Rwanda, Kigali, Rwanda.
Joselyne RugemaSchool of Nursing and Midwifery, College of Medicine and Health Science, University of Rwanda, Kigali, Rwanda.
Ancille MurekateteSchool of Nursing and Midwifery, College of Medicine and Health Science, University of Rwanda, Kigali, Rwanda.
Jean Pierre ManirafashaSchool of Nursing and Midwifery, College of Medicine and Health Science, University of Rwanda, Kigali, Rwanda.
Delphine MukandayisabaSchool of Nursing and Midwifery, College of Medicine and Health Science, University of Rwanda, Kigali, Rwanda.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Marburg viral disease is a highly virulent pathogen with acute hemorrhagic fever outbreaks. It has generally received less attention despite its ability to cause explosive outbreaks in humans and poses a threat to public health. Marburg Virus Disease remains significantly under-researched, with a notable lack of comprehensive scientific evidence. This limited attention has resulted in gaps in understanding its epidemiology, clinical management, and prevention strategies. Objective: This scoping review aims to explore the epidemiology, transmission dynamics, clinical manifestations, and public health interventions of Marburg viral disease. Methods: A scoping review methodology was used to collate relevant studies from global electronic databases published between 1975 and 2024. Articles reporting up on epidemiological data, transmission routes, clinical features, interventions and control prevention of Marburg viral disease were selected. This review followed the PRISMA guidelines. Results: Based on the review findings, Marburg viral disease outbreaks have been potentially occurring mainly in Sub-Saharan Africa. Marburg viral disease is zoonotically transmitted through direct contact of humans with infected bats and human-to-human through bodily fluids, greater risks for healthcare workers with inadequate infection control practices. Public health measures to combat it are case isolation, contact tracing, personal protective equipment, and community engagement. Conclusions: The course of Marburg viral disease is still highly a public health problem. Enhancing healthcare systems, surveillance and research on vaccines and therapeutics are critical in boosting preparedness.

Indexed as

Clinical ManifestationsEpidemiologyMarburg Viral DiseasePublic Health InterventionsTransmission Dynamics

Identifiers

PMID40989209
PMCPMC12451771

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.